These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 8091868)
1. [Side effects and efficiency of 15 mg and 25 mg methotrexate per week in chronic polyarthritis]. Schnabel A; Reinhold-Keller E; Willmann V; Dihlmann W; Gross WL Z Rheumatol; 1994; 53(3):142-9. PubMed ID: 8091868 [TBL] [Abstract][Full Text] [Related]
2. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial. Lambert CM; Sandhu S; Lochhead A; Hurst NP; McRorie E; Dhillon V Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477 [TBL] [Abstract][Full Text] [Related]
3. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone. Durez P; Malghem J; Nzeusseu Toukap A; Depresseux G; Lauwerys BR; Westhovens R; Luyten FP; Corluy L; Houssiau FA; Verschueren P Arthritis Rheum; 2007 Dec; 56(12):3919-27. PubMed ID: 18050189 [TBL] [Abstract][Full Text] [Related]
4. [Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis]. Gubar' EE; Bochkova AG; Bunchuk NV Ter Arkh; 2008; 80(5):25-30. PubMed ID: 18590110 [TBL] [Abstract][Full Text] [Related]
6. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group. Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358 [TBL] [Abstract][Full Text] [Related]
7. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Ruperto N; Murray KJ; Gerloni V; Wulffraat N; de Oliveira SK; Falcini F; Dolezalova P; Alessio M; Burgos-Vargas R; Corona F; Vesely R; Foster H; Davidson J; Zulian F; Asplin L; Baildam E; Consuegra JG; Ozdogan H; Saurenmann R; Joos R; Pistorio A; Woo P; Martini A; Arthritis Rheum; 2004 Jul; 50(7):2191-201. PubMed ID: 15248217 [TBL] [Abstract][Full Text] [Related]
8. [Basic therapy of rheumatoid arthritis. Comparison of methotrexate and sulfasalazine]. Keitel W; Keitel R; Pap T Z Gesamte Inn Med; 1993 Oct; 48(10):480-3. PubMed ID: 7903012 [TBL] [Abstract][Full Text] [Related]
9. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy. Rau R; Schleusser B; Herborn G; Karger T J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088 [TBL] [Abstract][Full Text] [Related]
10. Treatment of rheumatoid arthritis with higher dose intravenous methotrexate. Gabriel S; Creagan E; O'Fallon WM; Jaquith J; Bunch T J Rheumatol; 1990 Apr; 17(4):460-5. PubMed ID: 2348423 [TBL] [Abstract][Full Text] [Related]
11. [Experience with long term low dose methotrexate treatment in rheumatoid arthritis and arthritic psoriasis]. Náfrádi L; Varga L Orv Hetil; 1995 Jul; 136(29):1555-7. PubMed ID: 7637973 [TBL] [Abstract][Full Text] [Related]
12. Methotrexate dosage reduction in patients with rheumatoid arthritis beginning therapy with infliximab: the Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) trial. Fleischmann RM; Cohen SB; Moreland LW; Schiff M; Mease PJ; Smith DB; Keenan G; Kremer JM; Curr Med Res Opin; 2005 Aug; 21(8):1181-90. PubMed ID: 16083527 [TBL] [Abstract][Full Text] [Related]
13. Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies. Khanna D; Park GS; Paulus HE; Simpson KM; Elashoff D; Cohen SB; Emery P; Dorrier C; Furst DE Arthritis Rheum; 2005 Oct; 52(10):3030-8. PubMed ID: 16200612 [TBL] [Abstract][Full Text] [Related]
14. Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial. Cohen S; Hurd E; Cush J; Schiff M; Weinblatt ME; Moreland LW; Kremer J; Bear MB; Rich WJ; McCabe D Arthritis Rheum; 2002 Mar; 46(3):614-24. PubMed ID: 11920396 [TBL] [Abstract][Full Text] [Related]
15. Prospectively measured red cell folate levels in methotrexate treated patients with rheumatoid arthritis: relation to withdrawal and side effects. Andersen LS; Hansen EL; Knudsen JB; Wester JU; Hansen GV; Hansen TM J Rheumatol; 1997 May; 24(5):830-7. PubMed ID: 9150068 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of chronic polyarthritis with low-dose methotrexate]. Karger T; Rau R Dtsch Med Wochenschr; 1988 May; 113(21):839-46. PubMed ID: 3371211 [TBL] [Abstract][Full Text] [Related]
17. [Treatment of rheumatoid polyarthritis with methotrexate in Dakar: efficacy, tolerance and cost]. Ka MM; Diallo S; Ka EF; Diop BM; Pouye A; Mbengue M; Leye A; Diouf B; Diop TM Sante; 2000; 10(1):65-8. PubMed ID: 10827366 [TBL] [Abstract][Full Text] [Related]
18. Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus. Carneiro JR; Sato EI J Rheumatol; 1999 Jun; 26(6):1275-9. PubMed ID: 10381042 [TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial. Emery P; Fleischmann R; Filipowicz-Sosnowska A; Schechtman J; Szczepanski L; Kavanaugh A; Racewicz AJ; van Vollenhoven RF; Li NF; Agarwal S; Hessey EW; Shaw TM; Arthritis Rheum; 2006 May; 54(5):1390-400. PubMed ID: 16649186 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Maini RN; Breedveld FC; Kalden JR; Smolen JS; Davis D; Macfarlane JD; Antoni C; Leeb B; Elliott MJ; Woody JN; Schaible TF; Feldmann M Arthritis Rheum; 1998 Sep; 41(9):1552-63. PubMed ID: 9751087 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]